Incisive Genetics
Signal active
Organization
Contact Information
Overview
IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
About
Industries
Biotechnology, Health Care, Medical Device, Genetics
Founded
2018
Employees
1-10
Headquarters locations
North America
Social
N/A
Profile Resume
Incisive Genetics headquartered in North America, operates in the Biotechnology, Health Care, Medical Device, Genetics sector. The company focuses on Biotechnology and has secured $138.0M in funding across 48 round(s). With a team of 1-10 employees, Incisive Genetics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Incisive Genetics, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
3
Lead Investors
0
Total Funding Amount
$2.9M
Details
3
Incisive Genetics has raised a total of $2.9M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Seed | 376.0K | ||
| 2020 | Seed | |||
| 2021 | Seed | 2.5M |
Investors
Incisive Genetics is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Noel Hall | - | FUNDING ROUND - Noel Hall | 2.5M |
| Haig Farris | - | FUNDING ROUND - Haig Farris | 2.5M |
| Incisive Genetics | - | FUNDING ROUND - Incisive Genetics | 2.5M |
| Sandra MacPherson | - | FUNDING ROUND - Sandra MacPherson | 2.5M |
Recent Activity
There is no recent news or activity for this profile.